| Literature DB >> 25142060 |
Anna Lisowska1, Małgorzata Knapp, Agnieszka Tycińska, Piotr Sielatycki, Robert Sawicki, Paweł Kralisz, Włodzimierz J Musiał.
Abstract
Access-site vascular complications in patients undergoing transradial coronary procedures are rare but may have relevant clinical consequences. The aim of the study was to evaluate: (1) radial artery's (RA) patency immediately after the procedure and in long-term observation, (2) factors influencing the frequency of radial artery's occlusion (RAO) after percutaneous coronary intervention (PCI) procedures performed via transradial access in the group of 220 patients with acute coronary syndromes (ACS). RA ultrasound was performed 48-72 h after the procedure and in those who were diagnosed with RAO-again after 6-12 months. According to the ultrasonographic findings, the patients were divided into two sub-groups: 187 pts (85 %) with patent RA after PCI and 33 pts (15 %) with RAO. Both sub-groups significantly statistically differed with regard to the frequency of local hematomas-15 versus 27.3 % (p = 0.02), the frequency of applying IIbIIIa inhibitors in PCI-6.4 versus 15.1 % (p = 0.015) and procedure duration-0.59 ± 0.37 versus 0.77 ± 0.38 (p = 0.014), respectively. In a multifactorial analysis the only factor influencing RA patency promptly after the procedure was PCI duration (p < 0.05, r = -0.22). In the follow-up, right RA remained still obstructed in 28 patients (12.7 %) whereas in five patients (2.3 %) the regular flow in RA was resumed. The chronic RAO was clinically silent. Due to insignificant frequency of the occurrence of RAO after PCI procedure in patients with ACS as well as practically lack of clinical consequences of this artery's occlusion in long-term observation, we do not see any implications to routine ultrasound periprocedural RA evaluation.Entities:
Mesh:
Year: 2014 PMID: 25142060 PMCID: PMC4297298 DOI: 10.1007/s10554-014-0518-5
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Clinical characteristic of study group
| Whole study group (n = 220) | Patients with patent radial artery after PCI (n = 187) | Patients with occluded radial artery after PCI (n = 33) | p (pts with patent versus occluded radial artery) | |
|---|---|---|---|---|
| Age (y) | 64.0 ± 12.2 | 64.0 ± 11.9 | 63.4 ± 13.5 | NS |
| Men | 167 (75.6 %) | 147 (78.6 %) | 20 (60.6 %) | p = 0.025 |
| STEMI | 133 (60.2 %) | 110 (58.8 %) | 17 (51.5 %) | NS |
| NSTEMI | 88 (39.8 %) | 71 (38.0 %) | 14 (42.4 %) | NS |
| EF (%) | 46.7 ± 9.7 | 46.9 ± 9.2 | 45.7 ± 12.4 | NS |
| Creatinine (µmol/l) | 122.8 ± 21.0 | 130.8 ± 53.0 | 76.9 ± 21.2 |
|
| Total cholesterol (mmol/l) | 4.7 ± 1.1 | 4.6 ± 1.1 | 5.0 ± 1.25 | NS |
| LDL-cholesterol (mmol/l) | 3.0 ± 1.0 | 2.9 ± 1.0 | 3.3 ± 1.1 | NS |
| HDL-cholesterol (mmol/l) | 1.1 ± 0.3 | 1.1 ± 0.35 | 1.1 ± 0.3 | NS |
| Glucose(mmol/l) | 6.3 ± 1.8 | 6.4 ± 1.8 | 6.2 ± 1.2 | NS |
Procedural characteristic of study group
| Whole study group (n = 220) | Patients with patent radial artery after PCI (n = 187) | Patients with occluded radial artery after PCI (n = 33) |
| |
|---|---|---|---|---|
| Angiographically | ||||
| 1-vessel disease | 106 (47.9 %) | 94 (50.3 %) | 15 (45.5 %) | NS |
| 2-vessel disease | 63 (28.5 %) | 55 (29.4 %) | 11 (33.3 %) | |
| 3-vessel disease | 45 (20.4 %) | 38 (20.3 %) | 7 (21.2 %) | |
| PCI LAD | 100 (45.5 %) | 83 (44.4 %) | 15 (45.4 %) | NS |
| PCI RCA | 68 (30.9 %) | 56 (30.0 %) | 12 (36.3 %) | NS |
| PCI Cx | 52 (23.6 %) | 48 (25.7 %) | 6 (18.2 %) | NS |
| Stent (number of pts) | 204 (92.7 %) | 173 (92.5 %) | 31 (93.9 %) | NS |
| Number of patients with | ||||
| 1 stent | 149 (73.0 %) | 125 (72.5 %) | 24 (77.4 %) | NS |
| 2 stents | 51 (25 %) | 45 (26.0 %) | 6 (19.4 %) | |
| 3 stents | 4 (2.0 %) | 3 (1.7 %) | 1 (3.2 %) | |
| BMS (number of pts) | 167 (81.8 %) | 143 (82.6 %) | 24 (77.4 %) | NS |
| DES (number of pts) | 37 (18.1 %) | 30 (17.3 %) | 7 (22.6 %) | NS |
| Flow velocity in the right radial artery (cm/s) | 60.7 ± 19.2 | 0 | ||
| Flow velocity in the left radial artery (cm/s) | 62.8 ± 19.2 | 63.0 ± 17.4 | 62.1 ± 27.7 | NS |
| Local hematoma | 28 (15.0 %) | 9 (27.3 %) |
| |
| Dose of heparin during PCI | 5.85 ± 2.25 | 5.88 ± 2.26 | 5.64 ± 2,18 | NS |
| Blocker GP IIbIIIa during PCI | 17 (7.7 %) | 12 (6.4 %) | 5 (15.1 %) |
|
| PCI duration (hours) | 0.62 ± 0.37 | 0.59 ± 0.37 | 0.77 ± 0.38 |
|
| Previously PCI via radial artery | 13 (5.9 %) | 11 (5.9 %) | 2 (6.1 %) | NS |